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Simple Summary: Bone substitutes are commonly used when bone grafts are necessary in human
craniofacial surgery. To study the properties and biologic behaviour of those substitutes, they can be
implanted in experimental animals. A frequently used model involves the creation of critical-sized
defects (defects that are too large to heal by themselves) in the rabbits calvaria (the top part of the
skull). The procedure was initially described in 1989 and the authors considered and reported that
post-operative analgesia was not necessary. In our experience, this procedure is invasive and can
result in severe postoperative pain. The anaesthetic management of rabbits undergoing this procedure
is challenging. Most of the recent publications using this model fail to provide sufficient information
on perioperative animal management. With this report we have aimed to document a possible
practical and simple anaesthetic and postoperative management of rabbits undergoing this procedure.
Particular emphasis has been placed on postoperative pain assessment, duration and treatment.
Abstract: Calvarial bone surgery on rabbits is frequently performed. This report aims to document a
simple and practical anaesthetic and perioperative management for this procedure. Fourteen male New
Zealand white rabbits were included in the study. Subcutaneous (SC) dexmedetomidine, ketamine
and buprenorphine ± isoflurane vaporized in oxygen administered through a supraglottic airway
device (V-gel®) provided clinically suitable anaesthesia. Supplemental oxygen was administered
throughout recovery. Monitoring was clinical and instrumental (pulse-oximetry, capnography,
invasive blood pressure, temperature, arterial blood gas analysis). Lidocaine was infiltrated at the
surgical site and meloxicam was injected subcutaneously as perioperative analgesia. After surgery,
pain was assessed five times daily (composite behavioural pain scale and grimace scale). Postoperative
analgesia included SC meloxicam once daily for four days and buprenorphine every 8 h for three
days (unless both pain scores were at the lowest possible levels). Rescue analgesia (buprenorphine)
was administered in case of the score > 3/8 in the composite pain scale, >4/10 on the grimace scale
or if determined necessary by the caregivers. Airway management with a V-gel® was possible but
resulted in respiratory obstruction during the surgery in two cases. Hypoventilation was observed
in all rabbits. All rabbits experienced pain after the procedure. Monitoring, pain assessments and
administration of postoperative analgesia were recommended for 48 h.
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1. Introduction
Rabbits are a standardized animal model applied in the research of biomaterials used in bone
regenerative medicine [1–3]. One commonly performed surgical procedure is the creation of defects
in the calvarial bone [4–8]. An early description of this surgery stated that “postoperative analgesia
was not considered necessary” [9]. Recent publications using this model fail to provide sufficient
information on perioperative animal management [2–24] and do not comply with ARRIVE (Animal
Research: Reporting In Vivo Experiments) guidelines [25]. It is possible that many experimental
rabbits undergoing this procedure receive inappropriate perioperative analgesia. In our experience,
this procedure is invasive and can result in severe postoperative pain. Ethical concerns on the lack
of analgesia in experimental rabbits undergoing surgery have already been raised [26] and analgesia
recommendations for this surgical model were not found in the literature.
This manuscript aims to report a simple and practical anaesthetic and perioperative management
of New Zealand White rabbits undergoing calvarial bone surgery. Emphasis was placed on the
evaluation of postoperative pain and the description of an acceptable analgesia protocol.
2. Materials and Methods
2.1. Animals and Husbandry
All procedures were carried out with the approval of the Animal Care Committee of the
Canton of Bern, Switzerland (permission BE89/17) in accordance with current Swiss legislation on
Animal experimentation.
Fourteen 17-week old male New Zealand White Rabbits (Charles Rivers Laboratories, Romans,
France) entered this study. They were housed individually in suspended cages (Cage body P type,
970 × 895 × 1718 mm) and acclimatised for three weeks prior to the start of the experiment. To avoid
stereotypies, the space between two cages was left open permitting animal contact. In case of conflict,
a transparent separator was inserted between two cages to maintain visual contact. Each cage was
provided with an elevated platform, a wood block and a chew ball as enrichments. Animals were
kept on a 12:12 light:dark cycle (lights on at 06:30), room temperature was kept between 19–21 ◦C and
humidity at 45 ± 10 %, in compliance with GV-Solas guideline. Each rabbit received 200 g of standard
rabbit food (Provimi Kilba, Aargau, Switzerland) per day and water ad libitum.
2.2. Anaesthetic Management
The rabbits were moved from the housing unit (Central Animal Facilities) to the Experimental
Surgery Unit in individual cages the morning of the surgery (both facilities on the same campus).
Physical examination was performed by a trained veterinarian and animals were weighed on electric
scales. Dexmedetomidine 100 mcg kg−1 (Dexdomitor®; Provet AG, Lyssach, Switzerland), ketamine 15
mg kg−1 (Narketan®, Vetoquinol AG, Bern, Switzerland) and buprenorphine 30 mcg kg−1 (Temgesic®,
Rechitt Benckiser, Wallosellen, Switzerland) were mixed in a 2 mL syringe and injected subcutaneously
(SC) in the neck area with a 23 G needle. After the injection, the rabbits were left undisturbed for 10
to 12 min. Sedation was assessed and recorded by a single operator using a simple descriptive scale
that has been reported previously [27] (Table 1). Animals were taken out of their cages and positioned
in sternal recumbency on the preparation table. A small amount of eye unguent (Bepanthen Augen
und Nasenalbe, Bayer Vital GmbH, Leverkusen, Germany) was applied over the corneas, the eyelids
were gently massaged to ensure lubrication of the eyes, heads positioned in a non-tight facemask
and pure oxygen was administered at 2 L min−1. The ears were clipped and disinfected and a 22 G
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intravenous catheter (Vasofix® Safety, Bbraun, Melsungen AG, Germany) was inserted into the left
marginal vein. A 22 G catheter (Vasofix® Safety, BBraun Melsungen AG, Germany) was inserted into
one of the auricular arteries for invasive blood pressure monitoring and to facilitate blood sampling
during the procedure. The heads were clipped and aseptically prepared for surgery.
Table 1. Sedation scale [27] and quality of induction and condition for V-Gel® insertion modified from
Grint and Murison [28] used after anaesthesia agents administration in 14 rabbits undergoing surgical
creation of critical-sized defects in the calvarial bone.
Sedation Scale in Rabbits [27]
Variable Behaviour of the rabbit Score
Spontaneous posture
Normal 0
Sedated but standing/sitting with head up 1
Lying sternally head up 2
Lying sternally head down 3
Lying laterally, responding to stimuli 4
Lying laterally, not moving when stimulated 5
Resistance to being placed dorsally recumbent
Strong/normal resistance 0
Moderate resistance 1
Slight resistance 2
No resistance 3
Jaw relaxation Normal tonus 0
No resistance to mouth opening 1
Palpebral reflex
Normal 0
Decreased 1
Absent 2
Limb withdrawal in response to pinching
Normal 0
Decreased 1
No reaction 2
Total sedation score
Quality of Induction and Condition for V-gel® Insertion Modified from Grint and Murison [28]
Description Score
Excitement, and some struggling, requires additional intravenous ketamine to permit V-gel®
insertion
1
Some excitement, vigorous swallowing, additional ketamine needed to permit V-gel® insertion 2
Smooth induction but some swallowing and resistance to V-gel® insertion 3
Very smooth induction of anaesthesia, no swallowing during V-gel® insertion 4
The rabbits were moved to the operating theatre and positioned in sternal recumbency in a plastic
trough with open extremities ensuring a stable position without pressure on the chest and an accessible
head. After further pre-oxygenation via a facemask, a V-gel ® (Docsinnovent Ltd., London, UK)
connected to a side stream capnography monitor (Datex-Ohmeda S3, GE Healthcare Inc., Helsinki,
Finland) was inserted by a single trained operator. The correct positioning of the device was assessed
through visualization of successive CO2 curves on spontaneous breaths.
The ease of insertion of the supraglottic device was scored using a modification of a previously
published simple descriptive scale [28] (Table 1). In case of score of 1 or 2, further ketamine was
administered intravenously (IV) to effect by 0.5 mg kg−1 increments. If administered, the ketamine
dose was recorded. The rabbits were connected to a Mapleson F system (Jackson Rees modified T-piece
with the distal end of the bag connected to a fluoabsorber) and 1.5 to 2.5 L minute−1 of oxygen was
administered throughout the procedure. Isoflurane (0.5 to 2%) (Forene, Abbvie AG, Baar, Switzerland)
vaporized in oxygen was added if necessary and adjusted according to anaesthetic depth.
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Perioperative analgesia included the buprenorphine administered with the premedication,
meloxicam (0.3 mg kg−1) (Metacam®, Boehringer Ingelheim, Basel, Switzerland) injected SC in
the neck area and lidocaine 1% (1 mL) (Bichsel, Interlaken, Switzerland) infiltrated subcutaneously
at the surgical site before placement of the surgical drapes (approximately 3 to 5 min before surgery
started).
Intravenous fluid administration (NaCl 0.9%, 5 mL kg−1 h−1; B. Braun Medical AG, Sempach,
Switzerland) was initiated at the time of IV catheterization and continued throughout the procedure.
Perioperative antimicrobial prophylaxis consisted of procaine penicillin 150,000 IU mL−1 + benzathine
penicillin 150,000 IU mL−1 (Duplocillin ®, MSD Animal Health, Luzern, Switzerland), 0.01 mL kg−1
SC before surgery.
Monitoring of anaesthesia was: (1) clinically conducted by a veterinary anaesthetist and
(2) instrumentally conducted using a multiparametric anaesthesia monitor (Datex-Ohmeda S3,
GE Healthcare Inc., Helsinki, Finland), which included: (i) pulse-oximetry (SpO2), with a probe
placed on one of the digits of the pelvic limb, (ii) capnography (PE’CO2) and gas analysis connected
to the appropriate port of the V-gel®, (iii) invasive blood pressure (correctly configured and zeroed
transducer placed at the height of the heart and connected to the arterial catheter in an auricular artery)
and (iv) rectal temperature. Physiologic variables were recorded at 5 min intervals throughout the
procedure on a standard anaesthesia record made available online by the Association of Veterinary
Anaesthetists (AVA) [29]. Isoflurane requirement (vaporizer setting) was also recorded. Approximately
half way through the procedure, arterial blood gas analysis was performed. In the last four rabbits,
additional arterial blood gases were analysed immediately after the arterial catheter placement before
the beginning of the procedure approximately 15–20 min after the injection of the premedication drugs.
2.3. Surgical Procedure
Skin was incised on a 3 cm straight line from the nasal bone to the midsagittal crest. Periosteum
was elevated to allow exposure of the parietal bone. Two bone defects (10 mm) on each side of the
midline were created with a trephine bur under irrigation with sterile saline. Care was taken to
avoid injury of the dura. A drilling procedure with a trephine bur was done very carefully with low
speed (maximum 800 rpm) by trained cranio-maxillofacial surgeons. Drilling was stopped before
reaching the dura and the bone pieces were removed by blunt instruments such as mucosa elevators.
Under the conditions of the experiment, fresh blood needed to be mixed with the biomaterial under
investigation. Blood was therefore sampled from the catheterized auricular artery approximately half
way through the procedure (arterial blood gases were analysed at the same time). Following mixture,
the biomaterials were implanted directly into the bone defects. After implantation the periosteum and
skin were closed with interrupted sutures in layers using 4–0 Vicryl and 4-0 Monocryl sutures (Ethicon,
Somerville, NJ, USA). The wound surface was further protected with spray film dressing (Opsite®
spray, Smith & Nephew, London, UK).
2.4. Postoperative Management
At the end of the procedure isoflurane administration was discontinued in case it had been
initiated. The arterial cannula was removed and gentle compression was applied for 3 to 5 min.
The V-gel® was removed. The duration of anaesthesia, surgery and any eventual perioperative
complications were recorded.
Clinical monitoring was continued during the recovery period. The eyes were regularly lubricated.
Oxygen was administered by flow at 2 L minute−1 after removal of the supraglottic device. The rabbits
were placed on a soft mattress under infrared lights (150 Watts at approximately 50 cm) to provide an
external source of heat. Rectal temperature and SpO2 were regularly measured and skin temperature
was subjectively assessed. Intravenous fluids administration was continued at 3 to 5 mL kg−1 h−1 until
removal of the vascular access (IV catheters were removed after return of righting reflex). The time
to return of righting reflex was recorded. Once fully recovered (bright, alert, responsive, up to
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temperature, spontaneously moving around in their transport cage), the rabbits were returned to
their facility.
Pain was assessed using a composite behavioural pain scale and the evaluation of the rabbit
grimace scale (Table 2) [30,31]. Baseline scores were obtained using this evaluation during the three
days prior to surgery. Pain was assessed at standard time points before any drug administration by
one of three trained operators (06:00 am, 10:00 am and 14:00, S.G. 18:00, C.D.; 22:00, M.R.) on the day of
surgery and for the following three days (day 1, day 2 and day 3). The operators knew the rabbits
involved in this experiment, were familiar with the setting and the scores used and had experience
in pain assessment and recognition of rabbits and other species. Postoperative analgesia included
meloxicam 0.3 mg kg−1 SC once daily (10:00 am) for 4 days in all cases and buprenorphine 20–30 mcg
kg−1 (0.3 mL of Temgesic 0.3 mg mL−1/rabbit) SC three times daily (06:00 am, 14:00 and 22:00) for three
days after surgery unless both pain scores (composite and grimace) were at the lowest possible levels
(0/8 and 0/10). Rescue analgesia (SC buprenorphine 20–30 mcg kg−1: 0.3 mL of Temgesic 0.3 mg mL−1
/ rabbit) was administered at 10:00 am and 18:00 in case of a score of more than 3 in the composite
pain scale, more than 4 on the grimace scale or if subjectively considered necessary by the caregivers,
mostly based on behavioural assessment, despite scores lower than the cut-off values. Pain scores and
drugs administered were recorded on a standard hospitalization form.
Table 2. Composite behavioural pain scale and rabbit grimace scale [30,31] used by one of three
trained operators to assess pain in 14 rabbits undergoing surgical creation of critical-sized defects in the
calvarial bone at baseline, on the day of surgery and for 3 days after intervention at 06:00 am, 10:00 am,
14:00, 18:00 and 22:00.
Composite Behavioural Pain Scale
Variable Behaviour of the Rabbit Score
Attitude
Active, interested 0
Calm, move when touched 1
Immobile, consolidated, uninterested 2
Appetite
Normal, eating and drinking 0
Only drinking or only eating 1
Not eating or drinking 2
Mobility
Mobility is normal 0
Pain during action 1
Inactive 2
Appearance
Straight, bright pelt 0
Dull, slightly ruﬄed fur 1
Ruﬄed fur 2
Total score (Best = 0, Worst = 8)
Rabbit Grimace Scale [29,30]
Orbital Tightening
0
1
2
Cheek Flattening
0
1
2
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Table 2. Cont.
Composite Behavioural Pain Scale
Nose Shape
0
1
2
Whisker Position
0
1
2
Ear Position
0
1
2
Total Pain score (Best = 0, Worst = 10)
Particular attention was given to the overall behaviour of the rabbits and water and food intakes,
presence of urine and faeces in the litter (faecal output was monitored). Abdomens were palpated each
day. Animals were weighed 48 h after surgery. Weight loss of >10% was considered as an end-point.
2.5. Euthanasia
Between one and six months after the surgery, the rabbits were euthanised. After sedation with
SC ketamine 65 mg kg−1 (Narketan®, Vetoquinol AG, Bern, Switzerland) and xylazine 4 mg kg−1
(Xylazin 20 mg mL−1, Streuli Pharma AG, Uznach, Switzerland), pentobarbital sodium 150 mg kg−1
(Esconarkon®, Streuli Pharma AG, Uznach, Switzerland) was administered intravenously.
GraphPad Prism 7 for Mac OS X (GraphPad Software, La Jolla, CA, USA) was used for the
graphical representation of simple descriptive statistics. No statistical test was applied to this data set.
3. Results
The mean ± SD weight before surgery was 3.3 ± 0.4 kg. The median (range) sedation score was
13 (10–13). Individual sedation scores are presented in Table 3. Insertion of the V-gel was easy and
quick in most cases: the median (range) quality of the induction score was 4 (2–4) although two rabbits
required additional ketamine (0.5 mg kg−1 IV). Those rabbits were the two rabbits who scored lower
sedation scores (Rabbits 1 and 11) and were the first rabbits to be anaesthetized on the first and third
day of procedures. A R4 V-gel® was inserted into all but one rabbit (Number 11). That rabbit had a
smaller head compared to the others and the R4 V-gel® was too large to be advanced smoothly so
a R3 V-Gel® was placed. Despite pre-oxygenation, desaturation happened in several cases during
airway management. In two cases, obvious respiratory obstruction developed during the early stages
of surgery (increased inspiratory and expiratory efforts and inconsistent PE’CO2 values). The V-gels
were promptly removed and oxygen +/− isoflurane were administered via a tight facemask connected
to the Mapleson F breathing system for the rest of the procedure.
Individual isoflurane requirements are reported in Table 3. Isoflurane was not administered to 5/14
rabbits and the concentration administered was less than 1% in six others. The mean arterial pressure
(MAP) was generally between 60 and 80 mmHg although transient readings between 55 and 60 mmHg
were observed in some rabbits. Individual MAP, pulse rate and PE’CO2 ranges are reported in Table 3.
The blood gas could not be analysed in one animal as the arterial catheter was accidentally dislodged
before blood could be withdrawn; gentle compression was applied. Table 4 presents individual arterial
blood gas analysis. Marked hypercapnia (PaCO2 of 59 to 79 mmHg) developed in all but the first
rabbit. Arterial oxygen tension was between 99 and 407 mmHg in all but two animals: rabbit 3 before
insertion of the V-Gel® (68 mmHg) and rabbit 7 which had a facemask at the time of blood sampling
(77 mmHg). Base excess was between 0 and 21 and blood glucose concentration was elevated (between
10 and 21 mmol L−1). The individual duration of anaesthesia (55 to 80 min), surgery (30 to 45 min) and
return of righting reflex (20 to 55 min) are reported in Table 3.
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Table 3. Individual preoperative weight, sedation scores, quality score of induction and V-gel® insertion, pulse rate, mean arterial pressure, end tidal carbon dioxide
pressure, anaesthesia and surgery durations and return of righting reflex after anaesthesia in 14 rabbits undergoing surgical creation of critical-sized defects in the
calvarial bone.
Rabbit 1 2 3 4 5 6 7 * 8 9 10 11 * 12 13 14
Weight 3.7 3.2 3.8 3.3 3.5 3.4 3.4 3.3 3.5 3.6 3.5 3.3 3.5 3.3
Sedation score 10 13 13 13 13 12 13 13 13 13 10 13 13 13
Quality score 2 4 4 4 4 4 3 4 4 4 2 4 4 4
V-gel® R4 R4 R4 R4 R4 R4 FM R4 R4 R4 R3 R4 R4 R4
% iso 1–2.5 0.5-1.5 0–0.5 0.2–1 0.5–1.0 0.2–1.2 0 0 0.2–1 0–0.5 0–1 0 0 0
PR (minx–max) beats minute−1 200–250 204–221 195–214 151–182 128–157 155–216 174–198 130–184 134–175 170–183 154–208 169–187 132–165 170–185
MAP (min–max)(mmHg) 55–65 72–77 57–74 64–74 69–77 61–79 64–77 59–76 64–82 58–67 56–82 69–83 67–75 61–68
PE’CO2 (min–max)(kPa) 5.3–7.5 4.7–7.2 5.2–8.3 5.3–6.1 4.3–6.5 5.5–8.3 8.4–10.8 6.7–9.7 6.1–8.7 5.0–7.0 3.3–NA 5.6–6.8 4.8–6.4 5.0–6.7
PE’CO2 (min–max)(mmHg) 40–56 35–54 39–60 40–46 32–49 41–62 63–81 50–73 46–65 38–53 25–NA 42–51 36–48 38–50
Anaesth. Duration (min) 80 65 75 60 65 60 65 70 70 70 85 65 55 60
Surgery duration (min) 45 30 30 35 35 30 35 40 40 30 40 30 30 30
Return righting reflex (min) 20 45 35 35 35 25 25 45 25 25 20 40 35 55
FM: Facemask; MAP: Mean arterial pressure; PR: Pulse rate; PE’CO2: End tidal carbon dioxide. * Rabbits 7 and 11 had a facemask during surgery because of respiratory obstruction with
V-gel®.
Table 4. Intraoperative individual arterial blood gas analysis of 13 rabbits (1-3-4-5-6-7-8-9-10-11/2-12/2-13/2-14/2) undergoing surgical creation of critical-sized defects in
the calvarial bone, approximately 45 min after administration of medetomidine, ketamine and buprenorphine subcutaneously with or without isoflurane. Additional
arterial blood gas was analyzed in rabbits 11, 12, 13 and 14 approximately 15 to 20 min after injection (11/1-12/1-13/1-14/1).
Rabbit 1 2 3 4 5 6 7 * 8 9 10 11/1 11/2 * 12/1 12/2 13/1 13/2 14/1 14/2
pH 7.29 NA 7.36 7.39 7.40 7.41 7.30 7.27 7.35 7.35 7.46 7.35 7.23 7.24 7.34 7.29 7.31 7.36
PaO2 (kPa) 13.2 NA 31.1 37.3 49.7 48.3 10.3 39.1 43.4 47.3 54.3 45.3 25.3 43.1 9.1 50 23.3 43.6
PaO2 (mmHg) 99 NA 233 280 373 362 77 293 306 355 407 340 190 323 68 375 175 327
PaCO2 (kPa) 4.8 NA 9.3 8.8 9.9 8.8 8.8 10.5 10.0 8.3 6.0 9.1 8.9 10.5 7.9 9.9 7.9 9.2
PaCO2 (mmHg) 36 NA 70 66 74 66 66 79 75 62 45 68 67 79 59 74 59 69
BE 16 NA 13 14 21 18 7 10 16 8 9 12 0 6 6 9 4 14
Glucose (mmol L−1) 20 NA 21 18 17 18 15 15 16 17 13 24 10 15 13 20 10 19
Lactates (mmol L−1) 1.4 NA 1.0 1.0 0.9 1.1 0.5 1.1 1.3 0.7 1.9 1.2 0.9 0.5 1.9 1.0 2.5 0.6
BE: Base excess; NA: Not available PaO2: Arterial partial pressure of oxygen; PaO2: Arterial partial pressure of carbon dioxide. * Rabbits 7 and 11 had a facemask during surgery because of
respiratory obstruction with V-gel®.
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The evolution of the composite pain score and grimace scale in the three days following surgery
are presented in Figure 1A,B. All rabbits exhibited signs of pain in the post-operative period. Both pain
scores were back to their baseline values approximately 48 h after surgery. Figure 2 presents the
number of animals receiving buprenorphine at each evaluation time point, either scheduled (06:00 am,
14:00 and 22:00) or rescue (10:00 am and 18:00). All rabbits received buprenorphine every 8 h on the
day of surgery and 11 of them required rescue analgesia. Buprenorphine administration decreased
from day one after surgery. Weight loss was observed in all rabbits 48 h after surgery (3 to 6%).
Animals 2019, 9, x 8 of 13 
The evolution of the composite pain score and grimace scale in the three days following surgery 
are presented in Figures 1 and 2. All rabbits exhibited signs of pain in the post-operative period. Both 
pain scores were back to their baseline values approximately 48 h after surgery. Figure 3 presents the 
number of animals receiving buprenorphine at each evaluation time point, either scheduled (06:00 
am, 14:00 and 22:00) or rescue (10:00 am and 18:00). All rabbits received buprenorphine every 8 h on 
the day of surgery and 11 of them required rescue analgesia. Buprenorphine administration 
decreased from day one after surgery. Weight loss was observed in all rabbits 48 h after surgery (3 to 
6%). 
 
Figure 1. Evolution of composite pain scores (A) and the grimace scale (B) of 14 rabbits undergoing 
surgical creation of critical-sized defects in the calvarial bone assessed by one of three trained 
operators at baseline, on the day of surgery and for 3 days after intervention at 06:00 am, 10:00 am, 
14:00, 18:00 and 22:00. Minimum composite pain score is 0, maximum is 8; lowest grimace score is 0, 
maximum is 10. The boxes represent the values from the lower to the upper quartile, the ends of the 
whiskers the minimum and maximum values. The median values are represented by the lines in the 
boxes. 
 
Figure 2. Number of rabbits (out of 14) administered buprenorphine after each assessment (06:00 am, 
10:00 am, 14:00, 18:00 and 22:00), after surgical creation of critical-sized defects in the calvarial bone 
on the day of surgery and for 3 days after intervention at 06:00 am, 10:00 am, 14:00, 18:00 and 22:00. 
The top of the grey bars represents the number of animals treated. Postoperative analgesia included 
meloxicam once daily (10:00 am) for 5 days in all cases and buprenorphine three times daily (6:00 am, 
14:00 and 22:00) for three days after surgery unless both pain scores (composite and grimace) were at 
the lowest possible levels. Buprenorphine (rescue analgesia) was administered at 10:00 am and 18:00 
if necessary. 
Figure 1. Evolution of composite pain scores (A) and the grimace scale (B) of 14 rabbits undergoing
surgical creation of critical-sized defects in the calvarial bone assessed by one of three trained operators
at baseline, on the day of surgery and for 3 days after intervention at 06:00 am, 10:00 am, 14:00, 18:00 and
22:00. Minimum composite pain score is 0, maximum is 8; lowest grimace score is 0, maximum is
10. The boxes represent the values from the lower to the upper quartile, the ends of the whiskers the
minimum and maximum values. The median values are represented by the lines in the boxes.
Animals 2019, 9, x 8 of 13 
The evolution of the composite pain score and grimace scale in the three days following surgery 
are presented in Figures 1 and 2. All rabbits exhibited signs of pain in the post-operative period. Both 
pain scores were back to their baseline values approximately 48 h after surgery. Figure 3 presents the 
number of animals receiving bupr norphine at each ev luation time point, either scheduled (06:00 
m, 14:00 and 22:00) or rescue (10:00 am and 18:00). All rabbits received buprenorphine every 8 h o  
the day of surgery and 11 of them required rescue analgesia. B prenorphine administration 
decreased fro  day one after surgery. Weight loss was observed in all rabbits 48 h after surgery (3 to 
6%). 
 
Figure 1. Evolution of composite pain scores (A) and the grimace scale (B) of 14 rabbits undergoing 
surgical creation of critical-sized defects in the calvarial bone assessed by one of three trained 
operators at baseline, on the day of surgery and for 3 days after intervention at 06:00 am, 10:00 am, 
14:00, 18:00 and 22:00. Minimum composite pain score is 0, maximum is 8; lowest grimace score is 0, 
maximum is 10. The boxes represent the values from the lower to the upper quartile, the ends of the 
whiskers the minimum and maximum values. The median values are represented by the lines in the 
boxes. 
 
Figure 2. Number of rabbits (out of 14) administered buprenorphine after each assessment (06:00 am, 
10:00 am, 14:00, 18:00 and 22:00), after surgical creation of critical-sized defects in the calvarial bone 
on the day of surgery and for 3 days after intervention at 06:00 am, 10:00 am, 14:00, 18:00 and 22:00. 
The top of the grey bars represents the number of animals treated. Postoperative analgesia included 
meloxicam once daily (10:00 am) for 5 days in all cases and buprenorphine three times daily (6:00 am, 
14:00 and 22:00) for three days after surgery unless both pain scores (composite and grimace) were at 
the lowest possible levels. Buprenorphine (rescue analgesia) was administered at 10:00 am and 18:00 
if necessary. 
i i
: , : : : , f i ti f criti l l
i i : , : , : , : : .
t f t r ars re rese ts the n ber of ani als treated. t ti l i i l
l i il ( : ) f r i ll r r i t r ti il ( : ,
: : ) f r t r s ft r s r r l ss t i sc r s (c sit ri c ) r t
t l est ssi le le els. re i e (resc e al esia) as a i istere at 10:00 a 18:00
if necessary.
Animals 2019, 9, 896 9 of 13
The dura in the right bone defect of rabbit 14 was partially damaged during surgery resulting
in moderate bleeding. Recovery from anaesthesia was slower than in the other animals. Mentation
was reduced in the first hours after surgery and the animal developed head tilting and walking on the
circle. After 48 h of intensive observation and appropriate analgesia administration, this condition did
not improve. Weight loss was around 15%, therefore the rabbit was euthanized.
4. Discussion
The description of the presented anaesthetic and perioperative management raises several
clinically relevant aspects. First, the use of the V-gel® in this surgical procedure had the potential to
lead to respiratory obstruction. Second, hypoventilation and ventilation/perfusion inequalities were
documented in all animals and may have been unobserved without arterial blood gas analysis. Third,
despite early multimodal analgesia, rabbits undergoing this surgical procedure did show signs of pain
in at least the first 48 h after surgery. This is particularly 3R relevant as post-operative analgesia of
rabbits undergoing this surgical model is inconsistently reported.
The V-gel® placement was difficult in the two less sedated animals. Although V-Gel® insertion
was easy and successful in the other rabbits, respiratory obstruction developed in the early surgical
stages of two rabbits. Endotracheal intubation can be challenging in rabbits [32] although airway
management is recommended for long well-controlled periods of anaesthesia [33]. The V-Gel® is
specifically designed for rabbits [34] and has been shown to be a practical alternative to endotracheal
intubation and a laryngeal mask for airway management and controlled mechanical ventilation [35]
potentially causing less tissue damage than endotracheal intubation [36]. The V-Gel®, however, has
the potential to cause laryngeal compression without an obvious clinical sign [35]. The respiratory
obstruction observed in two out of 14 rabbits could be due to an incorrect placement of the device or
dislodgement during craniotomy; this highlights the importance of perioperative monitoring.
Arterial blood gas analysis documented ventilation–perfusion inequalities and lower arterial
oxygen tension than what could be expected in a small animal that is administered pure oxygen.
The rabbits enrolled in this experiment were obtained from a colony free of respiratory pathogens and
appeared clinically healthy. Hypoxaemia with a similar anaesthesia protocol without buprenorphine
has been documented in rabbits [37]. The low arterial oxygen tension could therefore be an effect of
our anaesthesia protocol. However, it may also suggest that the V-gel® was not completely sealing the
airway. This finding would have been unobserved had blood gases not been analysed as SpO2 was
> 95% throughout the procedure in all rabbits. This underlines the fact that oxygen administration in
the perianaesthetic context is reasonable in rabbits.
A sidestream capnograph and relatively high fresh gas flows were used so differences between
PE’CO2 and arterial PaCO2 are not surprising. Superiority of arterial blood gas analysis over PE’CO2
monitoring was already previously established in pet rabbits [38]. In all cases, hypoventilation was
documented approximately 45 min after sedation. Our anaesthesia protocol was adapted from current
literature [28,37,39–42]. A previous study investigated the effects of 0.03 mg kg−1 of buprenorphine in
rabbits one hour before the administration of a similar anaesthesia protocol (SC medetomidine 0.25
mg kg−1 and ketamine 15 mg kg−1) [40]. It was found that recoveries were longer but no respiratory
depression was observed 10 min after the administration of medetomidine and ketamine. In our
experiment, less alpha-2 agonist was used but buprenorphine was administered at the same time as the
other drugs. PaCO2 measured in the last four rabbits at the beginning of anaesthesia (approximately
15–20 min after injection) was lower than PaCO2 during the surgery but higher than what was reported
by Murphy et al. [40]. It is possible that simultaneous administration of all the drugs increased
respiratory depression. On the other hand, hypoventilation might have been unobserved in some of
the previous studies as blood gas analysis was performed fairly early after the administration of the
drugs. Its clinical relevance is still unknown.
Anaesthetic risk is higher in rabbits (overall 1.39%) than in other domestic species [43].
Perianaesthetic mortality mostly occurs after recovery from anaesthesia (64%) [43]. Many reasons can
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explain this, but it is likely that the lack of monitoring plays a major role. Hypoxaemia is frequent
with injectable protocols; our previous experience documented frequent desaturation in the recovery
phase. Because of their high surface/volume ratio, rabbits are prone to developing hypothermia during
anaesthesia [44]. Continuous monitoring, pain assessment, warming and oxygen supplementation
seem essential.
Despite early multimodal analgesia (opioid, non-steroidal anti-inflammatory drug and topical
local anaesthetic agent) every animal enrolled in this experiment experienced pain. This was a major
finding and contrasts the reports on the early application of this technique [25]. This may originate
from an improved pain assessment [30,45–47]. Scientists should be aware that the calvarial bone defect
model in rabbits may result in strong acute pain and that monitoring and analgesia administration
after this surgery is essential. Using a composite pain scale and the rabbit grimace scale allowed us to
identify times during the postoperative phase in which rabbits were likely to be in pain and require
additional analgesia. Pain reached a peak during the 12 h following surgery and the following day.
Analgesia was necessary every 4 to 8 h on the day of surgery and after 1.5 days; thereafter, most rabbits
appeared comfortable.
This study has several limitations. First, it is well established that the pain response is
sex-dependent [48]. The findings of the present report might thus apply to male rabbits only.
Second, animals were not filmed between pain assessments. Being prey species, it is possible that
the presence of an observer modified their behaviour and altered pain scores and expression. Third,
the descriptive pain scale used was not validated. It is however simple and rapid to use and allowed
for the establishment of cut off scores similar between operators. Fourth, a descriptive study is by
nature not blinded. Fifth, because of the low number of included animals, it is possible that some of the
complications were over-represented and that some other possible complications were not encountered.
The clinical relevance of the documented hypercapnia is unknown. Although outcomes were
mostly good from an anaesthesia point of view, peri-anaesthetic management can still be improved.
Future studies will look at investigating the impact of opioids and other factors on hypoventilation
during anaesthesia and will aim to further refine the post-operative analgesia protocol.
5. Conclusions
Within its limitations, the present report describes a simple and practical anaesthetic management
for rabbits undergoing calvarial bone surgery. Subcutaneous administration of dexmedetomidine,
ketamine and buprenorphine ± addition of low-dose isoflurane provided clinically suitable anaesthesia
of sufficient duration. Nevertheless, it resulted in marked hypoventilation of unknown clinical
importance. Airway management with a V-gel® was possible, but the continuous intraoperative
monitoring is important due to a potential respiratory obstruction. Rabbits will experience pain
after this surgical procedure and we recommend maximum postoperative monitoring and regular
administration of postoperative analgesia for 48 h after surgery. This is particularly 3R relevant as
post-operative analgesia of rabbits undergoing this surgical model is inconsistently reported.
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